3658 results for «247»
3658 results
Complex coronary artery disease: can stents and DCB be complementary?
16 May 2023 – From EuroPCR 2023
DES and DCB, can these two technologies be complementary for the treatment of the same patient? What are the advantages and how to proceed? You will know everything by watching this presentation based on concrete cases.
The importance of optimal vascular access and closure in TAVI patients
16 May 2023 – From EuroPCR 2023
In this session, a panel of experts focus on access and closure, a crucial aspect of TAVI. This discussion offers valuable insights into effective planning and achieving access for a TAVI procedure using echo guidance. It provides a step-by-step guide on closing a TAVI procedure using...
From proof to practice - Treating hypertension with ultrasound renal denervation
16 May 2023 – From EuroPCR 2023
Renal denervation: what are the latest clinical evidences and benefits? How to select the good candidate? How to establish a dedicated centre? All the anwers to these questions and more in this video.
Robotic PCI: real-life experience with a new robotic platform
16 May 2023 – From EuroPCR 2023
The current problems in interventional cardiology have been the same for years: exposure to X-rays, or orthopaedic injuries to operators after decades in the cathlab. The solution to these problems could lie in robotics and the increasing use of artificial intelligence in practice. Follow this session...
Lifetime management - Tailoring treatment options to secure future possibilities
16 May 2023 – From EuroPCR 2023
Check out this session if you want to better understand the importance of paravalvular leaks and conduction disorders after TAVI on long-term outcomes. You will also learn about the latest data on the lifetime management of patients with aortic stenosis, and value the importance of TAVI...
Physiologic guidance and optimisation in multivessel disease
16 May 2023 – From EuroPCR 2023
Follow the case study of this 70-year-old ex-smoker male patient with HTN, dyslipidemia, previous primary PCI to proximal and mid LAD because of anterolateral STEMI, presenting with syncope, and find out, through the debates around his treatment, how to use physiology in 2023.
Going down the road of coronary artery disease treatment: sirolimus-coated balloon and DES + DCB stent platform
16 May 2023 – From EuroPCR 2023
What better way to talk about sirolimus-coated balloons than with real-life clinical cases? In this session, study the case of a 78-year-old man with crescendo angina and inferior wall ischaemia, or a 48-year-old woman with crescendo angina, type 2 DM and anterior wall hypokinesia with mild...
EuroPCR 2023 Welcome Ceremony
16 May 2023 – From EuroPCR 2023
As we celebrate the 30th anniversary of primary PCI for STEMI this year, follow the retrospective of this major advance in interventional cardiology, before listening to William Wijns, Jean Fajadet and their guests take stock of the current STEMI care worldwide at this opening ceremony which launches...
Treating diverse mitral regurgitation anatomies: the power of versatility
16 May 2023 – From EuroPCR 2023
Based on a LIVE mitral TEER educational procedure and several case examples, this MR patient session will allow you to learn more about the PASCAL platform and system, as well as the latest clinical and real-world data on mitral TEER using the PASCAL system, while benefiting...
PCR Valves e-Course: Sponsored Programme
EuroIntervention: Meet Cory, your new AI Assistant!
26 Mar 2024
Since the launch of its new website in February, EuroIntervention has harnessed the power of AI, integrating this cutting-edge technology in the development and improvement of features such as an optimised user interface and a powerful search engine.
All-new EuroPCR 2021: what’s on?
MERIL announces successful primary outcomes of next-gen Myval THV series in major RCT, presented at EuroPCR 2024 - Earns prestigious late Breaking trial status & The LANCET acceptance.
15 May 2024
EuroPCR 2024 – Early outcomes of a randomised non-inferiority trial comparing TAVI devices: the LANDMARK trial
15 May 2024
Paris, France, 14-17 May 2024. The Course Directors have selected 3 major Late Breaking Trials (LBTs) that will be presented for the first time during the 2024 edition of EuroPCR. These trials were selected on account of their design, outcomes and potential to influence daily clinical...
Frequency and safety of bioprosthetic valve fracture in patients undergoing valve in valve TAVR for failed surgical valves using the SAPIEN 3/Ultra Valves: Insights from real-world data
19 Sep 2022
Michele Pighi provides his take on this trial which aimed to compare the safety and efficacy of VIV-TAVI with or without bioprosthetic valve fracture. It was presented by Santiago Garcia during the TCT Congress 2022.
Author
Long-term beta-blocker treatment after acute myocardial infarction and preserved left ventricular ejection fraction: The REDUCE-AMI Trial
07 Apr 2024
REDUCE-AMI is a multicentre, registry-based, prospective open-label parallel-group randomised clinical trial evaluating the benefit of beta-blocker treatment in patients with acute MI and an ejection fraction >50% treated with a contemporary reperfusion strategy.
Nicola Ryan and Ali Nazmi Calik provide their take on the results which were presented...
Author
Author
When transfemoral TAVI is not an option: rethinking alternative access strategies
18 Jun 2026
In this article, Ulrich Schäfer explores the evolving landscape of access strategies in transcatheter aortic valve implantation (TAVI). While the transfemoral approach remains the gold standard, a significant proportion of patients are not suitable due to peripheral vascular disease or anatomical constraints.
Drawing on clinical evidence and...
Author
ILUMIEN IV: OPTIMAL PCI - Optical Coherence Tomography Guided Coronary Stent Implantation Compared with Angiography: A Multicenter Randomized Trial in Percutaneous Coronary Intervention
29 Aug 2023
Claudio Laudani and Daniele Giacoppo report the main results of the ILUMIEN IV trial presented by Ziad Ali, from the St. Francis Hospital, Roslyn, and Clinical Trials Center, Cardiovascular Research Foundation, New York, in a Hot Line session at the European Society of Cardiology congress 2023...
Author
Author
